0.077 (0.132%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Laboratorios Farmaceuticos Rovi, S.A.
Telephone
34.91.021.30.00
Address
Pozuelo de Alarcón, Calle José Isbert, 2, Madrid 28223
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 50 - 87.5
Trade Value (12mth)
US$364,896.00
1 week
-1.16%
1 month
-31.89%
YTD
-7.87%
1 year
12.24%
All time high
93.90
EPS 3 yr Growth
-26.50%
EBITDA Margin
27.40%
Operating Cashflow
€185m
Free Cash Flow Return
26.10%
ROIC
19.80%
Interest Coverage
71.50
Quick Ratio
1.60
Shares Outstanding (Fully Diluted)
51m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
13-Jul-26
Next Dividend Pay Date
15-Jul-26
Reporting Currency
EUR
Short Sell (% of issue)
0.00
Historical data
Forecast data
| 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | GBP |  | | | | 3.29 | 2.68 | 2.75 | | | | ||
EPS (Fully Diluted) | GBP | | | | | 3.29 | 2.68 | 2.75 | | | | ||
Growth | % | | | | | -12 | -18.6 | 2.6 | | | | ||
PE | X | | | | | 18.3 | 23.5 | 23.1 | | | | ||
EV/EBITDA | X | | | | | 13 | 16.1 | 16.2 | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
